In order to identify additional actionable therapeutic targets in CIC-DUX4 sarcomas, we integrated CIC-DUX4–dependent gene expression changes with functional kinase activity screens in cells derived from patients with CIC-DUX4 sarcoma to identify candidate kinases that enable CIC-DUX4 survival (Figure 1A). This evidence concerns the gene DUX4 and sarcoma.